Pain Americain LLC – Trademark Portfolio
Entity Type: 16
Pain Americain LLC holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 5 filings in this category. The portfolio also extends into Class 43 (Hotels & Restaurants) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include CAFE D'AVIGNON, CAFÉ D'AVIGNON, THE TIPSY BAKER, and THE TIPSY BAKER BY CAFE D'AVIGNON. The owner is based in New York, NY.
35-20 9th Street Long Island City
New York, NY 11106
Showing of trademarks Trademarks
Trademark Classifications
Pain Americain LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does Pain Americain LLC have?
Pain Americain LLC has 5 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 abandoned.
What trademark classes does Pain Americain LLC file in?
Pain Americain LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 43 (Hotels & Restaurants), Class 30 (Staple Foods). Class 35 covers advertising; business management; business administration; office functions.
What are Pain Americain LLC's most well-known trademarks?
Pain Americain LLC's registered trademark portfolio includes well-known marks such as CAFE D'AVIGNON, CAFÉ D'AVIGNON, THE TIPSY BAKER, and THE TIPSY BAKER BY CAFE D'AVIGNON. These are among 4 currently registered trademarks in the portfolio.
What is Pain Americain LLC's trademark registration success rate?
Pain Americain LLC has a 80% trademark registration rate, with 4 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.